Comparing 2 hypotheses side-by-side
## Mechanistic Overview SARM1-Mediated NAD+ Depletion as Terminal Executor of MCT1-Dependent Axon Degeneration starts from the claim that modulating SARM1, NMNAT2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "# SARM1-Mediated NAD⁺ Depletion as Terminal Executor of MCT1-Dependent Axon Degeneration ## Background and Conceptual Framework Axon degeneration represents a convergent pathological endpoint across diverse neurodeg
## Mechanistic Overview Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration starts from the claim that modulating NLRP3, CASP1, IL1B, PYCARD within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration starts from the claim that modulating NLRP3, CASP1, IL1B, PYCARD within the disease context of neurodeg
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | SARM1-Mediated NAD+ Depletion | Gut Microbiome Remodeling to P |
|---|---|---|
| Mechanistic | 0.700 | 0.800 |
| Evidence | 0.580 | 0.690 |
| Novelty | 0.850 | 0.500 |
| Feasibility | 0.550 | 0.720 |
| Impact | 0.720 | 0.000 |
| Druggability | 0.650 | 0.900 |
| Safety | 0.600 | 0.600 |
| Competition | 0.800 | 0.800 |
| Data | 0.500 | 0.800 |
| Reproducible | 0.550 | 0.700 |
| KG Connect | 0.077 | 0.332 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.82
# Mechanistically-Specific Hypotheses: MCT1 Dysfunction and Neuronal Damage --- ## Hypothesis 1: AMPK-ULK1 Autophagy Dysregulation Link **Title:** AMPK Deficiency Drives Axonal Autophagy Failure ...
# Critical Evaluation of Mechanistic Hypotheses ## Hypothesis 1: AMPK-ULK1 Autophagy Dysregulation ### Strongest Specific Weakness The hypothesis contains an **unverified causal chain** with a cr...
# Translational Evaluation: MCT1 Dysfunction and Axonal Degeneration in Alzheimer's Disease ## Executive Assessment The fundamental translational challenge here is that the proposed hypotheses add...
{"ranked_hypotheses":[{"rank":1,"title":"AMPK-ULK1 Autophagy Dysregulation","mechanism":"MCT1 disruption reduces axonal lactate transport, depleting ATP and suppressing AMPK activity below threshold...
4 rounds · quality: 0.95
# Novel Therapeutic Hypotheses for Gut-Brain Axis in Parkinson's Disease ## Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway **Title:** Targeting Bacterial Curli Fibrils to Prevent α-Synuclein C...
# Novel Therapeutic Hypotheses for Gut-Brain Axis in Parkinson's Disease ## Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway **Title:** Targeting Bacterial Curli Fibrils to Prevent α-Synuclein C...
# Critical Evaluation of Gut-Brain Axis Hypotheses in Parkinson's Disease ## Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway ### Weaknesses in Evidence: - **Cross-seeding specificity**: The su...
# Critical Evaluation of Gut-Brain Axis Hypotheses in Parkinson's Disease ## Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway ### Weaknesses in Evidence: - **Cross-seeding specificity**: The su...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["Intestinal Dysbiosis
Pathogenic bacterial
overgrowth"] --> B["Increased Intestinal
Permeability
Leaky gut syndrome"]
B --> C["LPS Translocation
Bacterial endotoxin
enters circulation"]
C --> D["TLR4 Activation
Pattern recognition
on immune cells"]
D --> E["NF-kappaB Signaling
Transcriptional
activation pathway"]
E --> F["NLRP3 Priming
Upregulation of
inflammasome components"]
E --> G["Pro-IL1B Expression
Inactive cytokine
precursor synthesis"]
E --> H["Pro-CASP1 Expression
Inactive caspase-1
precursor synthesis"]
C --> I["Microglial TLR4
Brain-resident immune
cell activation"]
I --> J["CNS NLRP3 Priming
Neuroinflammatory
sensitization"]
K["Neuronal DAMPs
Amyloid-beta aggregates
ATP release"] --> L["NLRP3-PYCARD
Oligomerization
Signal 2 activation"]
F --> L
J --> L
L --> M["Active CASP1
Caspase-1 cleavage
and activation"]
H --> M
M --> N["Mature IL1B
Pro-inflammatory
cytokine secretion"]
G --> N
N --> O["Sustained Neuroinflammation
Chronic microglial
activation state"]
O --> P["Blood-Brain Barrier
Dysfunction
Vascular permeability"]
O --> Q["Oxidative Stress
ROS production
cellular damage"]
P --> R["Progressive
Neurodegeneration
Cognitive decline"]
Q --> R
S["Microbiome Remodeling
Therapeutic intervention
probiotic treatment"] --> T["Restored Gut Barrier
Reduced intestinal
permeability"]
T --> U["Reduced LPS
Translocation
Decreased endotoxemia"]
U --> V["Prevented NLRP3
Priming
Neuroprotective effect"]
classDef normal fill:#4fc3f7,stroke:#2196f3
classDef therapeutic fill:#81c784,stroke:#4caf50
classDef pathology fill:#ef5350,stroke:#f44336
classDef outcome fill:#ffd54f,stroke:#ff9800
classDef molecular fill:#ce93d8,stroke:#9c27b0
class A,B,C pathology
class D,E,F,G,H,I,J,K,L,M,N molecular
class O,P,Q normal
class R outcome
class S,T,U,V therapeutic